ArticleBMC veterinary research2025
Performance of 1-year-old camel calves fed a basal ration of alfalfa hay supplemented with different levels of concentrate.
Article in BMC veterinary research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Effects of replacing alfalfa hay with Atriplex nummularia on the growth performance, digestibility, and energy usage of six-month old camel calves.BMC veterinary research · 2026Article
- Integrative analysis of genetic, biochemical, and microbial factors in camel calf diarrhea.Veterinary research communications · 2026Article
- Effects of concentrate supplement on camel performance, forage utilization, and energy usage in arid-area rangelands.BMC veterinary research · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe use of a high-concentrate diet in fattening camels may have significant effects on growth performance and digestion as well as economic returns. This experiment was designed to study the effects of feeding different levels of concentrate in their diet on growth performance and digestion in a desert climate.
methodsEighteen 12-month-old male camel calves were used, and divided into three treatments of six each. The concentrate was administered based on their body weight (BW) at 0.7 (low), 1.0 (medium), and 1.3% (high), with free access to alfalfa and water. The experiment lasted for 6 months, in which digestibility trials took place at 14, 16, and 18 months of age, which corresponded to 2, 4, and 6 months of the experimental period.
resultsNo significant variations were observed in final BW, BW changes, or average daily gain among feeding treatments. Increasing the concentrate level had a negative effect on roughage intake, impacting the roughage-to-concentrate ratio (P < 0.05) and neutral detergent fiber digestibility (P < 0.05). Increasing concentrate levels significantly increased total intake (P < 0.05), leading to a worse feed conversion ratio (P < 0.05). However, animal age had no negative effect on nutrient digestibility, and there were no interactions between concentrate supplement level and animal age. Significant increases in plasma total protein (P < 0.05) and urea (P < 0.05) were observed when the leve lof concentrate was increased. A similar trend was observed in rumen ammonia concentration. Camel calves fed low vs. medium or high levels of concentrate showed a greater rumen pH (P < 0.05), which was linked to a lower concentration of volatile fatty acids (P < 0.010).
conclusionsThe present study concluded that yearling camel calves receiving different levels of concentrate with ad lib alfalfa hay could cover their nutrient requirements for maintenance and growth with a daily gain of 630 g/day when the level of concentrate was limited to 0.7% of BW and the total intake was only around 1.65% of BW, or 70.6 g/kg metabolic BW.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.